| Literature DB >> 1462998 |
L F Roy1, L R Dufresne, L Legault, H Long, C Morin.
Abstract
Acetazolamide is a weak diuretic used to decrease production of aqueous humor in the eye. Hemodialysis patients undergoing ocular surgery may benefit from acetazolamide; however, no pharmacokinetic data are available for this group of patients. We report a patient who received acetazolamide 250 mg every 6 hours after ophthalmic surgery and developed reversible neurological side effects associated with very high plasma concentrations. Using pharmacokinetic analysis, we suggest an alternate administration of acetazolamide for end-stage renal patients.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1462998 DOI: 10.1016/s0272-6386(12)70235-4
Source DB: PubMed Journal: Am J Kidney Dis ISSN: 0272-6386 Impact factor: 8.860